Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study Assessing The Pharmacokinetics, Pharmacodynamics, Safety And Tolerability Of Subcutaneous Bolus And Subcutaneous Infusion Of Cenderitide In Patients With Chronic Heart Failure With Volume Overload (HF)

NCT01316432 is registered in ClinicalTrials.gov with Nile Therapeutics as lead sponsor.

NCT NCT01316432
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01316432 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study Assessing The Pharmacokinetics, Pharmacodynamics, Safety And Tolerability Of Subcutaneous Bolus And Subcutaneous Infusion Of Cenderitide In Patients With Chronic Heart Failure With Volume Overload (HF)
Lead sponsor
Nile Therapeutics
Phase
Phase 1
Overall status
Completed
Start date
May 31, 2011
Completion date
November 30, 2011
Enrollment
58 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

adhf, chf, chronic heart failure, heart failure